Effector cells of anaphylaxis: Mast cells and basophils

Novartis Foundation Symposium

Volumn 257, Issue , 2004, Pages 65-74

  Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AUTACOID; BIOLOGICAL MARKER; ISOENZYME; SERINE PROTEINASE; TRYPTASE;

ANAPHYLAXIS; AUTOIMMUNITY; BASOPHIL; BLOOD; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; MAST CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYSTEMIC MASTOCYTOSIS;

ALLERGENS; ANAPHYLAXIS; AUTOIMMUNITY; BASOPHILS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLAMMATION MEDIATORS; ISOENZYMES; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 2342649478     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (23)

1. Chandrasekharan NV, Dai H, Roos KL et al 2002 COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931
2. Evans JF 2002 Cysteinyl leukotriene receptors. Prostaglandins Other Lipid Mediat 68-69:587-597
3. Fricker M, Helbling A, Schwartz L, Muller U 1997 Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 100:11-15
4. Guida M, Riedy M, Lee D, Hall J 2000 Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog. Pharmacogenetics 10:389-396
5. Hirai H, Tanaka K, Yoshie O et al 2001 Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193:255-261
6. Huang C, Li L, Krilis SA et al 1999 Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J Biol Chem 274:19670-19676
7. Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B 2001 Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 357:361-362
8. Marquardt U, Zettl F, Huber R, Bode W, Sommerhoff C 2002 The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region. J Mol Biol 321:491-502
9. Neugut AI, Ghatak AT, Miller RL 2001 Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 161:15-21
10. Sakai K, Ren S, Schwartz LB 1996 A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest 97:988-995
11. Schwartz LB 2001 Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res 25:553-562
12. Schwartz LB 2002 Mast cells and basophils. Clin Allergy Immunol 16:3-42
13. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T 1987 Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316:1622-1626
14. Schwartz LB, Yunginger JW, Miller JS, Bokhari R, Dull D 1989 The time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83:1551-1555
15. Schwartz LB, Bradford TR, Rouse C et al 1994 Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 14:190-204
16. Schwartz LB, Sakai K, Bradford TR et al 1995 The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 96:2702-2710
17. Schwartz LB, Min H, Ren S et al 2003 Tryptase precursors are preferentially and spontaneously released, while mature tryptase is retained by HMC-1 cells, monomac-6 cells and human skin-derived mast cells. J Immunol 170:5667-5673
18. Selwood T, Wang ZM, McCaslin DR, Schechter NM 2002 Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue differences at the S1 pocket. Biochemistry 41:3329-3340
19. Soto D, Malmsten C, Blount JL, Muilenburg DJ, Caughey GH 2002 Genetic deficiency of human mast cell α-tryptase. Clin Exp Allergy 32:1000-1006
20. Valent P, Horny H-P, Escribano L et al 2001 Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603-625
21. van der Linden P-WG, Hack CE, Poortman J, Vivié-Kipp YC, Struyvenberg A, van der Zwan JK 1992 Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 90:110-118
22. Wedemeyer J, Tsai M, Galli SJ 2000 Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 12:624-631
23. Wolters PJ, Pham CTN, Muilenburg DJ, Ley TJ, Caughey GH 2001 Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J Biol Chem 276:18551-18556